Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 E Thomas Rd
Phoenix, AZ 85016Phone+1 602-933-0920
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Baylor College of Medicine (Houston)Residency, Pediatrics, 2008 - 2011
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2008
Certifications & Licensure
AZ State License 2019 - 2026
CO State License 2010 - 2021
OH State License 2014 - 2016- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors Start of enrollment: 2015 Jun 01
- Tocilizumab in Children With ACP Start of enrollment: 2019 Sep 06
- Pediatric Long-Term Follow-up and Rollover Study Start of enrollment: 2019 Nov 04
- Join now to see all
Publications & Presentations
PubMed
- 35 citationsPhase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium studyLindsey M. Hoffman, Maryam Fouladi, James M. Olson, Vinay M. Daryani, Clinton F. Stewart
Child's Nervous System. 2015-05-01 - 34 citationsFractionated stereotactic radiosurgery for recurrent ependymoma in children.Lindsey M. Hoffman, S. Reed Plimpton, Nicholas K. Foreman, Nicholas V. Stence, Todd C. Hankinson
Journal of Neuro-Oncology. 2014-01-01 - 173 citationsCharacterization of Distinct Immunophenotypes across Pediatric Brain Tumor TypesAndrea Griesinger, Diane K. Birks, Andrew M. Donson, Vladimir Amani, Lindsey M. Hoffman
Journal of Immunology. 2013-11-01
Journal Articles
- Correction to: A Suggestion to Introduce the Diagnosis of “Diffuse Midline Glioma of the Pons, H3 K27 Wildtype (WHO Grade IV)”Lindsey M Hoffman, Maryam Fouladi, Acta Neuropathologica
Press Mentions
- SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain CancerSeptember 13th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
